Human Milk Oligosaccharide Market Expected to Surge at 6.5% CAGR by 2034 Amid Growing Population and Demand for Infant Nutrition Products | Future Market Insights, Inc.
Future Market Insights Global and Consulting Pvt. Ltd.
Future Market Insights Global and Consulting Pvt. Ltd.

The drug store or pharmacy segment is expected to hold the largest share of the global human milk oligosaccharides (HMO) market during the forecast period

NEWARK, Del, March 13, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the global human milk oligosaccharide (HMO) market is estimated to reach US$ 100.8 million in 2024. Over the forecast period, human milk oligosaccharide sales are poised to increase at a CAGR of 6.5%. The global market is estimated to reach US$ 161.6 million by 2034.

Escalating demand for infant formula products that emulate the nutritional composition of breast milk is driving the human milk oligosaccharide market. As awareness of breast milk's unique benefits grows, parents and caregivers are seeking human milk oligosaccharides that closely resemble breast milk for optimal infant nutrition.

Rising birth rates, urbanization, and the growing prevalence of working mothers are the factors contributing to a greater reliance on human milk oligosaccharides as a primary source of infant nutrition. Advancements in extraction and purification technologies are making HMOs more accessible to formula manufacturers and other industries seeking to incorporate them into their products.

Unlock Growth Potential in Your Industry - Get Your Sample Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4252

Leading companies are investing in research & development to innovate novel HMO structures. They are forming strategic partnerships with infant formula manufacturers and implementing efficient production processes for cost-effectiveness and scalability.

Key Takeaways from the Human Milk Oligosaccharide Market Report:

  • The global human milk oligosaccharide market is estimated to be US$ 100.8 million in 2024.

  • The global market is expected to surge at a CAGR of 6.5% by 2034.

  • Based on product type, the fucosylated segment is expected to reach a valuation of US$ 42.9 million by 2034.

  • During the forecast period, China is expected to rise at a CAGR of 5.5%.

  • Demand for human milk oligosaccharides in Japan is anticipated to rise at a steady CAGR of 4.8% by 2034.

"The human milk oligosaccharide (HMO) market is experiencing robust growth fueled by rising awareness of their health benefits and expanding applications beyond infant nutrition. As demand continues to surge, innovations in production technologies and regulatory advancements are set to be pivotal in shaping the market's trajectory and fostering further development." -says Nandini Roy Choudhury (client Partner for Food and Beverages at Future Market Insights, Inc.)